StockData

Novavax Inc (NVAX) stock

NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$7.96+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

Novavax market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Novavax's market cap was $1.64B on Nov 11, 2026, against $1.15B a year earlier. Over the last 5 years it ranged from $474.92M to $10.79B, with a median of $1.34B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.64B+50.7%
2025Dec 31, 2025$1.09B-15.2%
2024Dec 31, 2024$1.29B+125.9%
2023Dec 29, 2023$569.91M-29.4%
2022Dec 30, 2022$806.74M-92.5%
2021Dec 31, 2021$10.79B+53.8%
2020Dec 31, 2020$7.02B+6806.3%
2019Dec 31, 2019$101.60M-85.6%
2018Dec 31, 2018$704.22M+83.1%
2017Dec 29, 2017$384.62M+12.5%
2016Dec 30, 2016$341.76M-84.9%
2015Dec 31, 2015$2.26B+60.1%
2014Dec 31, 2014$1.41B+32.5%
2013Dec 31, 2013$1.07B+327.4%
2012Dec 31, 2012$249.77M+72.5%
2011Dec 30, 2011$144.81M–

More Novavax figures

See a number that looks wrong?